"Thrombolytic Therapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Use of infusions of FIBRINOLYTIC AGENTS to destroy or dissolve thrombi in blood vessels or bypass grafts.
| Descriptor ID |
D015912
|
| MeSH Number(s) |
E02.319.913
|
| Concept/Terms |
Thrombolytic Therapy- Thrombolytic Therapy
- Therapeutic Thrombolysis
- Therapeutic Thrombolyses
- Thrombolyses, Therapeutic
- Thrombolysis, Therapeutic
- Therapy, Fibrinolytic
- Fibrinolytic Therapies
- Therapies, Fibrinolytic
- Therapy, Thrombolytic
- Therapies, Thrombolytic
- Thrombolytic Therapies
- Fibrinolytic Therapy
|
Below are MeSH descriptors whose meaning is more general than "Thrombolytic Therapy".
Below are MeSH descriptors whose meaning is more specific than "Thrombolytic Therapy".
This graph shows the total number of publications written about "Thrombolytic Therapy" by people in this website by year, and whether "Thrombolytic Therapy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 2 | 0 | 2 |
| 1994 | 0 | 1 | 1 |
| 1995 | 2 | 1 | 3 |
| 1996 | 0 | 1 | 1 |
| 1997 | 0 | 1 | 1 |
| 1998 | 1 | 2 | 3 |
| 1999 | 0 | 2 | 2 |
| 2000 | 1 | 0 | 1 |
| 2001 | 2 | 3 | 5 |
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 2 | 2 |
| 2004 | 0 | 1 | 1 |
| 2005 | 1 | 2 | 3 |
| 2006 | 2 | 2 | 4 |
| 2007 | 1 | 2 | 3 |
| 2008 | 2 | 0 | 2 |
| 2009 | 2 | 1 | 3 |
| 2010 | 1 | 3 | 4 |
| 2011 | 10 | 1 | 11 |
| 2012 | 11 | 2 | 13 |
| 2013 | 6 | 4 | 10 |
| 2014 | 5 | 1 | 6 |
| 2015 | 5 | 5 | 10 |
| 2016 | 5 | 1 | 6 |
| 2017 | 3 | 0 | 3 |
| 2018 | 3 | 3 | 6 |
| 2019 | 4 | 3 | 7 |
| 2020 | 2 | 5 | 7 |
| 2021 | 4 | 4 | 8 |
| 2022 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Thrombolytic Therapy" by people in Profiles.
-
Race-Ethnic Disparities in Rates of Declination of Thrombolysis for Stroke. Neurology. 2022 04 19; 98(16):e1596-e1604.
-
(More than) doubling down: Effective fibrinolysis at a reduced rt-PA dose for catheter-directed thrombolysis combined with histotripsy. PLoS One. 2022; 17(1):e0261567.
-
Design and Characterization of an Ultrasound Transducer for Combined Histotripsy-Thrombolytic Therapy. IEEE Trans Ultrason Ferroelectr Freq Control. 2022 01; 69(1):156-165.
-
In Reply: Intracerebral Hemorrhage Volume Reduction and Timing of Intervention Versus Functional Benefit and Survival in the MISTIE III and STICH Trials. Neurosurgery. 2021 09 15; 89(4):E247-E248.
-
Post-Trial Enhanced Deployment and Technical Performance with the MISTIE Procedure per Lessons Learned. J Stroke Cerebrovasc Dis. 2021 Sep; 30(9):105996.
-
An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug. J Vis Exp. 2021 06 04; (172).
-
Safety and efficacy of catheter-directed therapy versus anticoagulation alone in a higher-risk acute pulmonary embolism population. J Thromb Thrombolysis. 2021 Nov; 52(4):1151-1159.
-
Intracerebral Hemorrhage Volume Reduction and Timing of Intervention Versus Functional Benefit and Survival in the MISTIE III and STICH Trials. Neurosurgery. 2021 04 15; 88(5):961-970.
-
Diagnosis and Management of Transient Ischemic Attack and Acute Ischemic Stroke: A Review. JAMA. 2021 Mar 16; 325(11):1088-1098.
-
Analysis of Mechanical Thrombectomy for Acute Ischemic Stroke on Nights and Weekends Versus Weekdays at Comprehensive Stroke Centers. J Stroke Cerebrovasc Dis. 2021 Apr; 30(4):105632.